Prospective of ischemic stroke biomarkers

1. Brouns R., De Deyn P.P.: The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg., 111, 483, 2009.Search in Google Scholar

2. Castellanos M. et al.: Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study. Stroke, 38, 1855, 2007.10.1161/STROKEAHA.106.48155617478737Search in Google Scholar

3. Chen S. et al.: Asymmetric Dimethyarginine as Marker and Mediator in Ischemic stroke. Int. J. Mol. Scien., 13, 15983, 2012.10.3390/ijms131215983354667423443106Open DOISearch in Google Scholar

4. Chorong H., Ki-Sook H.: Apolipoprotein B/A1 Ratio as Risk Factor for Cerebral Ischemic Stroke. Ewha Med. J., 35, 21, 2012.Search in Google Scholar

5. Craig J.S. et al.: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology, 4, 2, 2004.Search in Google Scholar

6. Fouda A.Y. et al.: Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response. Exp. Transl Stroke Med., 5, 12, 2013.10.1186/2040-7378-5-12384353024499655Search in Google Scholar

7. Greisenegger S. et al.: Biomarkers and Mortality After Transient Ischemic Attack and Minor Ischemic Stroke Population-Based Study, Stroke, 46, 659,2015.10.1161/STROKEAHA.114.007624482004825649803Search in Google Scholar

8. Hanson E. et al.: Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. J. Thromb. Haemost., 9, 275, 2011.10.1111/j.1538-7836.2010.04134.x21054779Open DOISearch in Google Scholar

9. Heeb M.J. et al.: Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells, Mol. Dis., 29, 139, 2002.10.1006/bcmd.2002.054912490280Open DOISearch in Google Scholar

10. Iskra T. et al.: Hemostatyczne markery uszkodzenia śródbłona w udarze niedokrwiennym spowodowanym chorobami małych i dużych naczyń. Pol. Merkur. Lekarski, 21, 429, 2006.Search in Google Scholar

11. Jauch E.C. et al.: Association of Serial Biochemical Markers With Acute Ischemic Stroke. Stroke, 37, 2508, 2006.10.1161/01.STR.0000242290.01174.9e16960091Search in Google Scholar

12. Jensen J.K. et al.: Osteoprotegerin concentrations and prognosis n acute ischaemic stroke. J. Intern. Med., 267, 410, 2010.10.1111/j.1365-2796.2009.02163.x19895657Search in Google Scholar

13. Jickling G.C., Frank R. Sharp F.R.: Biomarker Panels in Ischemic Stroke. Stroke, 46, 915, 2015.Search in Google Scholar

14. Jong-Ho P. et al.: High Levels of Apolipoprotein B/AI Ratio Are Associated With Intracranial Atherosclerotic Stenosis. Stroke, 42, 3040, 2011.10.1161/STROKEAHA.111.62010421868729Search in Google Scholar

15. Jóźwicka M., Głąbiński A.: The search for inflammatory biomarkers of ischaemic stroke. Aktualn. Neurol., 11, 106, 2011.Search in Google Scholar

16. Kim M.H. et al.: Plasma biomarkers in the diagnosis of acut ischemic stroke. Ann. Clin. Lab. Sci., 40, 336, 2010.Search in Google Scholar

17. Kim S.J., Moon G.J., Banga O.Y.: Biomarkers for Stroke. Journal of Stroke, 15(1), 27, 2013.10.5853/jos.2013.15.1.27377967324324937Search in Google Scholar

18. Lioutas V.A., Novak V.: Intranasal insulin neuroprotection in ischemic stroke. Neural. Regen. Res., 11, 400, 2016.10.4103/1673-5374.179040482899427127468Open DOISearch in Google Scholar

19. 19. Marquardt L. et al.: Course of platelet activation markers after ischemic stroke. Stroke, 33, 2570, 2002.10.1161/01.STR.0000034398.34938.2012411644Search in Google Scholar

20. Nishiyama Y. et al.: Asymmetric dimethylaarginine (ADMA) as a possible risk marker for ischemic stroke. J. Neurol. Scien., 290, 12, 2010.10.1016/j.jns.2009.12.02020060545Search in Google Scholar

21. Palasik W.: Homocysteina - czynnik ryzyka występowania niedokrwiennego udaru mózgu. Postępy Nauk Medycznych, 14, 18, 2001.Search in Google Scholar

22. Park S.Y. et al.: Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome. Cli. Neurol. Neurosurg., 115, 405, 2013.10.1016/j.clineuro.2012.06.00422766253Search in Google Scholar

23. Radwan W., Rabbah A., Saber H., Elghonemi M.: A new marker for ischemic cerebrovascular stroke: Phosphorylated Neurofilament H. The Egyptian Journal of Critical Care Medicine, 1, 105, 2013.Search in Google Scholar

24. Rodriguez-Grande B.: Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia, Journal of Neuroinflammation, 12, 15, 2015.10.1186/s12974-014-0227-y430893825616391Search in Google Scholar

25. Rothstein L., Jickling G.C.: Ischemic stroke biomarkers in blood. Biomarkers in Medicine, 7, 37, 2013.Search in Google Scholar

26. Ryu W.S. et al.: Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis, 220, 581, 2012.10.1016/j.atherosclerosis.2011.11.03622178425Search in Google Scholar

27. Shenhar-Tsarfaty S. et al.: Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack. Int. J. Stroke, 5, 16, 2010.10.1111/j.1747-4949.2009.00396.x20088988Search in Google Scholar

28. Shimizu H. et al.: Plasma homocysteine concentrations and the risk of subtypes of cerebral infarction. Cerebrovasc Dis., 13, 9, 2002.10.1159/00004773911810004Search in Google Scholar

29. Smolders B., Lemmens R., Thijs V.: Lipoprotein (a) and stroke: a meta-analysis of observational studies. Strok,. 38, 1959, 2007. Search in Google Scholar

30. Song T.J. et al.: Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. Biomarkers, 17, 738, 2012.10.3109/1354750X.2012.72702723030274Open DOISearch in Google Scholar

31. Tanne D. et al.: Soluble intercellular adhesionmolecule-1 and risk of future ischemic stroke: a nestedcase-control study from the Bezafibrate Infarction Prevention(BIP) study cohort. Stroke, 33, 2182, 2002.10.1161/01.STR.0000029007.32244.4012215584Search in Google Scholar

32. Tomita H. et al.: Elevated plasma brain natriuretic peptide levels independent of heart disease in acut ischemic stroke: correlation with stroke severity. Hypertens. Res., 31, 1695, 2008.10.1291/hypres.31.169518971547Search in Google Scholar

33. Tran H.A., Eikelboom J.W.: Role of protein Z in stroke. Options Cardio. Med., 9, 191, 2007.Search in Google Scholar

34. Tuttolomondo A. et al.: Plasma levels of inf lammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol., 215, 84, 2009.Search in Google Scholar

35. Waje-Andreassen U. et al.: IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol. Scand., 111, 360, 2005.10.1111/j.1600-0404.2005.00416.x15876336Search in Google Scholar

36. Węglewski A.: Biochemiczne markery uszkodzenia mózgu. Postępy Psychiatrii i Neurologii, 12, 111, 2003.Search in Google Scholar

37. Welsh P. et al.: Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis., 27, 247, 2009.10.1159/00019682319176958Open DOISearch in Google Scholar

38. Wiseman S. et al.: Blood Markers of Coagulation, Fibrinolysis, Endothelial Dysfunction and Inflammation in Lacunar Stroke versus Non-Lacunar Stroke and Non-Stroke: Systematic Review and Meta- Analysis. Cerebrovasc Dis., 37, 64, 2014.Search in Google Scholar

39. Wunderlich M.T. et al.: Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J. Neurol., 252, 718, 2005.10.1007/s00415-005-0725-z15834650Search in Google Scholar

40. Yi-Chinn W., Wen-Hai Ch.: Neutrophil Gelatinase-Associated Lipocalin and Matrix Metalloproteinase-9 as Potential Biomarkers for Stroke: A Pilot Study. J. Neurol. Neurophysiol., 6, 2, 2015.Search in Google Scholar

41. Yip H.K. et al.: Link between platelet activity and outcomes after an ischaemic stroke. Cerebrovasc. Dis., 20, 120-128, 2005.10.1159/00008680216006760Search in Google Scholar

42. Żerdziński M., Rychlik M., Partyka R.: Rola selektyn w rozwoju odpowiedzi zapalnej. Journal of Laboratory Diagnostics, 48, 347, 2012.Search in Google Scholar